Page 86 | Certara

Case Study

Using customer engagement technology to create value communication tools for ABILIFY MAINTENA® (aripiprazole)

Otsuka identified several weaknesses in their existing workflow for developing value communication tools. In particular,…

CertaraOctober 2, 2023

On-Demand Webinar

Unlocking ROI through Omnichannel Stakeholder Engagement and Value Communication in Pharma

In a sector where both competition and stakeholder expectations are high, a comprehensive approach that…

CertaraOctober 2, 2023

Blog

Developing Pediatric PBPK Models for Differing Ethnic Populations

Physiologically-based pharmacokinetic (PBPK) modeling has proven invaluable in drug development, especially for pediatric populations, because…

CertaraSeptember 29, 2023

Press Coverage

What recent paediatric guidelines mean for drug developers

Justin Hay, Senior Director, Amy Cheung Senior Director of Integrated Drug Development, and Patrick Loebs…

CertaraSeptember 25, 2023

Conference

2024 KIC: KoNECT-MOHW-MFDS International Conference

CertaraSeptember 22, 2023

Blog

Maximizing Reusability for Drug Submissions to Different Health Authorities

Many drug developers have products that they want to submit for marketing approval in several…

CertaraSeptember 21, 2023

Poster

FDA Trends for Accelerated Drug Approvals in Oncology Indications

The FDA has modified and increased expectations around data needed to support accelerated approvals in…

CertaraSeptember 20, 2023

Poster

Adoption of PROs in Early Clinical Trials for Oncology Drugs: Challenges and Opportunities

Despite changes in regulatory expectations, adoption of PROs in early-phase oncology trials remains very low…

CertaraSeptember 20, 2023

Poster

PBPK Application in Drug Discovery and Development

Real-World Application of Physiologically Based Pharmacokinetic Modeling (PBPK) in Support of Decision-Making During Drug Discovery;…

CertaraSeptember 20, 2023

Blog

Top Lessons Learned from 300 Regulatory Submissions

Who would have thought when we completed work on the first submission for which we…

CertaraSeptember 20, 2023

Using customer engagement technology to create value communication tools for ABILIFY MAINTENA® (aripiprazole)

Unlocking ROI through Omnichannel Stakeholder Engagement and Value Communication in Pharma

Developing Pediatric PBPK Models for Differing Ethnic Populations

What recent paediatric guidelines mean for drug developers

2024 KIC: KoNECT-MOHW-MFDS International Conference

Maximizing Reusability for Drug Submissions to Different Health Authorities

FDA Trends for Accelerated Drug Approvals in Oncology Indications

Adoption of PROs in Early Clinical Trials for Oncology Drugs: Challenges and Opportunities

PBPK Application in Drug Discovery and Development

Top Lessons Learned from 300 Regulatory Submissions

Newsletter sign up

Quick links

Solutions

Contact